Axogen, Inc.

AXGN ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $-1.5M $-19.6M $-13.2M $708.0K $579.0K $-3.8M $450.0K $-1.9M
Depreciation & Amortization $1.6M $1.6M $1.6M $1.6M $1.7M $1.7M $1.6M $1.7M
Depreciation $1.6M $1.6M $1.6M $1.6M $1.7M $1.7M $1.6M $1.7M
Amortization $111.0K $101.0K $94.0K $88.0K $66.0K $67.0K $64.0K $65.0K
Stock-Based Compensation $8.8M $6.8M $16.6M $5.4M $5.2M $2.9M $3.1M $5.0M
Net Cash from Operating Activities $7.2M $1.6M $3.0M $3.2M $7.7M $-13.2M $8.7M $3.9M
Investing Activities
Capital Expenditures $893.0K $2.8M $1.2M $1.5M $722.0K $256.0K $670.0K $597.0K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $500.0K $-16.0M $4.0M $-3.8M $-6.9M $1.3M $-813.0K $-5.0M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $4.2M $59.5M $4.6M $2.4M $1.2M $2.4M $970.0K $572.0K
Net Change in Cash $11.9M $45.1M $11.6M $1.9M $1.9M $-9.5M $8.9M $-527.0K
Free Cash Flow $6.3M $-1.2M $1.8M $1.7M $7.0M $-13.4M $8.1M $3.3M
← Newer Page 1 of 8 Older →